Banner for leaf pages 2

Ziprasidone (Geodon)

Also known as Geodon


Ziprasidone (marketed as Geodon, Zeldox by Pfizer) was the fifth atypical antipsychotic to gain approval (February 2001) in the United States. It is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia, and acute mania and mixed states associated with bipolar disorder. Its intramuscular injection form is approved for acute agitation in schizophrenic patients for whom treatment with just ziprasidone is appropriate.

Source: Wikipedia

Estimated Total Cost: $410.62 for an average of 28 days supply

What is it prescribed for?

Patients are most commonly prescribed ziprasidone to treat bipolar disorder, schizophrenia, depressive or psychotic symptoms, and psychotic disorder.

Ajax-loader Loading...